Antimicrobial peptides may modulate host defense against influenza virus infections.
Beta-defensin pretreatment leads to a reduction in pandemic H1N1 virus burden in the lungs.
Beta-defensin pretreatment alters the innate immune profile in response to H1N1 influenza virus.